Dark Forest Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-45,319
Closed -$832K 1201
2024
Q4
$832K Sell
45,319
-29,225
-39% -$472K 0.12% 221
2024
Q3
$1.15M Buy
74,544
+41,634
+127% +$695K 0.15% 142
2024
Q2
$535K Buy
+32,910
New +$531K 0.1% 256
2023
Q4
Sell
-95,735
Closed -$2M 435
2023
Q3
$2M Buy
95,735
+30,769
+47% +$836K 0.17% 129
2023
Q2
$1.56M Buy
64,966
+56,388
+657% +$1.25M 0.16% 136
2023
Q1
$161K Buy
+8,578
New +$163K 0.04% 485
2022
Q1
Sell
-232
Closed -$5K 1213
2021
Q4
$5K Sell
232
-415
-64% -$8.35K ﹤0.01% 1132
2021
Q3
$11K Buy
+647
New +$12.5K ﹤0.01% 965

Other funds holding ACAD